Valuation DexCom, Inc. Boerse Muenchen
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Real-time
Boerse Muenchen
22:43:09 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 77.59 EUR | -0.26% |
|
+2.14% | +36.04% |
| 08-25 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
| 08-13 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 34,015 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 31.41% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 33,254 | 32,954 | 32,139 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 26.88% | -0.9% | -2.47% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 36.1x | 30.4x | 25.1x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 12x | 9.97x | 7.67x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.9x | 1.6x | 1.2x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.5x | 5.86x | 5.26x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 6.36x | 5.68x | 4.97x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 20x | 17.2x | 14.5x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 26.7x | 22.8x | 18.7x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 32.6x | 27x | 21.9x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.07% | 3.7% | 4.57% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.495 | 2.969 | 3.596 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,230 | 5,800 | 6,461 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,666 | 1,920 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,247 | 1,445 | 1,722 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 974.4 | 1,149 | 1,409 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 90.14 | 90.14 | 90.14 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 31.25x | 4.22x | 16.23x | 2.36% | 188B | ||
| 20.48x | 3.6x | 12.83x | 3.13% | 118B | ||
| 18.12x | 0.21x | 13.2x | 0.72% | 63.16B | ||
| 30.51x | 7.53x | 19.44x | 1.31% | 52.01B | ||
| 36.06x | 3.47x | 11.88x | 2.1% | 50.97B | ||
| 36.13x | 6.36x | 19.96x | -.--% | 34.02B | ||
| 46.08x | 1.3x | 12.07x | 0.17% | 30.8B | ||
| 39.49x | 6.91x | 24.81x | 0.27% | 23.83B | ||
| 19.29x | 3.02x | 10.82x | 1.46% | 23.45B | ||
| Average | 30.82x | 4.07x | 15.69x | 1.28% | 64.95B | |
| Weighted average by Cap. | 28.94x | 3.92x | 15.25x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
















